Uniogen Secures US Patent for Optical Breakthrough in Lateral Flow Readers

We’re excited to announce that Uniogen has been granted US Patent for a groundbreaking optical innovation designed to elevate the performance of lateral flow (LF) test strip readers (US Patent No. US12228743B2).

At the heart of this invention is a novel optical component that creates a homogenized and freely formed excitation light spot, precisely focused across the entire test line area. This results in maximized signal intensity – ensuring that all bound label molecules are detected with the highest sensitivity possible.

What makes it exceptional

The patented technology

  • Applies to all excitation light wavelengths – from ultraviolet (UV) to visible and infrared (IR) light.
  • Is compatible with all detection technologies using excitation light like fluorescence, time-resolved fluorescence (TRF) and Upcon® (Uniogen proprietary photon upconversion technology).
  • Increases significantly the detection accuracy and precision in LF measurements.

A corresponding European patent is pending.

Abacus Diagnostica, Kaivogen and Labrox are now Uniogen

Uniogen is a global pioneer in clinical diagnostics, point-of-care testing, and instrumentation for life sciences.

Uniogen – Enabling diagnosis and care at first appointment